The use of ultrasound in detecting and guiding non-palpable tumor resection in breast conservation surgery after chemotherapy: A pilot study
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C50-C50- Malignant neoplasms of breast
- Registration Number
- CTRI/2020/04/024578
- Lead Sponsor
- Regional Cancer Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients with non-palpable residual lesion(radiologically detected) after NACT in breast cancer undergoing BCS in RCC, Trivandrum
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare adequacy of margin status by intraoperative ultrasound with frozen section analysis and final histopathology reportTimepoint: 1 month after surgery
- Secondary Outcome Measures
Name Time Method To determine the rate of margin positivity and re-excision <br/ ><br>To assess the impact of IOUS on resection volumes and cosmetic outcome <br/ ><br>Timepoint: 1 month after surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What is the role of intraoperative ultrasound in detecting non-palpable breast tumors after neoadjuvant chemotherapy?
How does intraoperative ultrasound compare to standard imaging techniques in breast conservation surgery outcomes?
Are there specific biomarkers that correlate with residual non-palpable breast cancer detection using ultrasound?
What are the potential adverse events associated with ultrasound-guided tumor resection in breast surgery?
What combination therapies or imaging modalities are being explored alongside ultrasound for breast cancer resection?